Back    Zoom +    Zoom -
<Research>HSBC Global Research Rates CHINA LIFE (02628.HK) at Hold on Strong NP Growth
Recommend
7
Positive
11
Negative
5
HSBC Global Research's report wrote that CHINA LIFE (02628.HK) posted a 4.8% YoY growth in NBV on a like-for-like basis in 1Q25, while FYP slid 4.5%, and the number of agents dropped 3.1% compared to the full year of 2024.

The broker noted that China Life delivered strong net profit growth, on the back of a steep cut in insurance service expenses. HSBC Global Research maintained a target price of HKD14 for CHINA LIFE H-shares and a Hold rating.

Related NewsCiti: CHINA LIFE 1Q25 NP Drastically Outruns Peers; TP $17.7

AAStocks Financial News